TR200200616T2 - Dökülebilir sıvı araçları - Google Patents

Dökülebilir sıvı araçları

Info

Publication number
TR200200616T2
TR200200616T2 TR2002/00616T TR200200616T TR200200616T2 TR 200200616 T2 TR200200616 T2 TR 200200616T2 TR 2002/00616 T TR2002/00616 T TR 2002/00616T TR 200200616 T TR200200616 T TR 200200616T TR 200200616 T2 TR200200616 T2 TR 200200616T2
Authority
TR
Turkey
Prior art keywords
pourable liquid
compositions
liquid vehicles
tools
substances
Prior art date
Application number
TR2002/00616T
Other languages
English (en)
Inventor
Joseph Dobrozsi Douglas
William Hayes Ii Jerry
Olof Lindman Bjorn
Hristova Ivanova Rouja
Alexandridis Paschalis
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR200200616T2 publication Critical patent/TR200200616T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
  • Polyethers (AREA)

Abstract

Mevcut bulus bilesimler, malzemeler ve maddelerle birlestirilebilen dökülebilir sivi araçlariyla ilgilidir. Bu tip dökülebilir sivi araçlarin yararlarindan birisi, bilesimlerin, malzemelerin ve maddelerin nemli bir yüzeye etki etmelerini saglamaya yetecek bir süreyle, akma veya asinmaya direnç göstererek bilesimlerin bahsedilen yüzey üzerinde kalmalaridir. Bu tip dökülebilir sivi araçlar nesnelerin ve ayni zamanda canlilar dahil biyolojik veya canli organizmalarin yüzeylerinin temizlenmesi ve tedavi edilmesi dahil, fakat bunlarla kisitli degil, çesitli kullanimlara sahiptir.
TR2002/00616T 1999-09-11 2000-09-11 Dökülebilir sıvı araçları TR200200616T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15326099P 1999-09-11 1999-09-11

Publications (1)

Publication Number Publication Date
TR200200616T2 true TR200200616T2 (tr) 2002-06-21

Family

ID=22546438

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00616T TR200200616T2 (tr) 1999-09-11 2000-09-11 Dökülebilir sıvı araçları

Country Status (12)

Country Link
US (1) US6503955B1 (tr)
EP (1) EP1212091B1 (tr)
JP (1) JP2003509350A (tr)
CN (1) CN1373674A (tr)
AT (1) ATE355082T1 (tr)
AU (1) AU770516B2 (tr)
CA (1) CA2383570C (tr)
DE (1) DE60033671T2 (tr)
ES (1) ES2282134T3 (tr)
MX (1) MXPA02002607A (tr)
TR (1) TR200200616T2 (tr)
WO (1) WO2001019329A2 (tr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230030B1 (hu) 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
PT1321140E (pt) * 2000-08-25 2005-06-30 Kowa Co Solucoes de ibuprofeno para o enchimento de capsulas e preparacoes de capsula
EP1609468A3 (en) * 2000-11-22 2006-01-25 Rxkinetix, Inc. A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
EP1560584B1 (en) 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab i inhibitors
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
EP1575951B1 (en) * 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
US20060140985A1 (en) * 2003-01-10 2006-06-29 Zhong Zhang Lansoprazole formulations and related processes and methods
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
JP2006008696A (ja) * 2003-03-20 2006-01-12 Mitsubishi Pharma Corp アルギニンアミド類を含有する医薬製剤
DE602004021248D1 (de) * 2003-04-03 2009-07-09 Seed Co Ltd Kontaktlinsen mit der fähigkeit einer andauernden medikamentenfreigabe und schutzlösungen dafür
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
EP1696878A1 (en) * 2003-12-11 2006-09-06 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics
CA2635603C (en) * 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
US20070196329A1 (en) * 2006-01-20 2007-08-23 Erning Xia Disinfection efficacy of lens care regimen for rigid gas permeable contact lenses
US8703195B2 (en) * 2006-03-10 2014-04-22 Biorem Ag Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
WO2012135422A2 (en) * 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
ITFI20110241A1 (it) * 2011-11-03 2013-05-04 Lo Li Pharma Srl Formulazioni per migliorare la probabilità di fecondazione ed il numero di gravidanze
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
UY36570A (es) * 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
EP3915540A1 (en) 2017-02-01 2021-12-01 Johnson & Johnson Consumer Inc. A lozenge
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100271A (en) 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4511563A (en) 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
PT83095B (en) * 1985-07-30 1987-12-23 Int Minerals & Chem Corp Method for the stabilization of growth promoting hormones using polyoxyethylene-polyoxypropylene copolymers
DE3532562A1 (de) 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US5030448A (en) 1986-05-15 1991-07-09 Emory University Method of delivering drugs to damaged or diseased tissue
US4810503A (en) 1987-03-31 1989-03-07 Basf Corporation Polymers which form gels at low concentrations in water
US5681576A (en) * 1988-11-16 1997-10-28 Mdv Technologies, Inc. Method and composition for post surgical adhesion reduction
US4911926A (en) 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5135751A (en) 1988-11-16 1992-08-04 Mediventures Incorporated Composition for reducing postsurgical adhesions
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5298260A (en) 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5306501A (en) 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5292516A (en) 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
US5071644A (en) 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5143731A (en) 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
CN1106259A (zh) 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
AU1332997A (en) 1995-12-11 1997-07-03 Mdv Technologies, Inc. Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers

Also Published As

Publication number Publication date
MXPA02002607A (es) 2002-07-30
JP2003509350A (ja) 2003-03-11
ATE355082T1 (de) 2006-03-15
AU7128200A (en) 2001-04-17
DE60033671T2 (de) 2007-12-06
CA2383570C (en) 2008-08-12
AU770516B2 (en) 2004-02-26
WO2001019329A2 (en) 2001-03-22
EP1212091A2 (en) 2002-06-12
WO2001019329A3 (en) 2001-08-02
ES2282134T3 (es) 2007-10-16
CN1373674A (zh) 2002-10-09
DE60033671D1 (de) 2007-04-12
US6503955B1 (en) 2003-01-07
CA2383570A1 (en) 2001-03-22
EP1212091B1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
TR200200616T2 (tr) Dökülebilir sıvı araçları
HU9303537D0 (en) Water disperable organic polysiloxane composition
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
DE69934229D1 (de) Zusammensetzung zur entschichtung von photolack und organischen materialien von substratoberflächen
DK1005271T3 (da) Synergistisk biocidsammensætning
ATE433280T1 (de) Biostatische beschichtungen zur minderung und verhütung von bakterienansätzen
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
DE60023872D1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
ID25752A (id) Senyawa-senyawa piretroid dan komposisi untuk mengontrol hama yang mengandung senyawa-senyawa tersebut
DE50015780D1 (de) Reinigungsmittel für glaskeramische oberflächen
BR9801705B1 (pt) composiÇço de liberaÇço controlada e processo para controlar ou inibir o crescimento de fungos, bactÉrias, algas, organismos que provocam sujeira marinha, plantas e isentos.
WO1998026033A3 (en) Cleaning compositions containing a halogen bleaching agent and a sulfosuccinate salt
FI960829A0 (fi) Puunsuoja-aineena käytettävät oksatiatsiinit
ATE271780T1 (de) Hemmung von durch sulfat-reduzierende bakterien vermitteltem abbau durch verwendung von bakterien,die antimirkobrobielle stoffe ausscheiden
AR002253A1 (es) Compuesto derivado de fenil-alcanol biocida composición que lo contiene y procesos para producirlo
NO982360D0 (no) Sammensetning for behandling av flekker pÕ skittent°y, samt fremgangsmÕter ved behandling
CO5050275A1 (es) Composiciones liquidas para la limpieza de superficies duras
CA2422678A1 (en) Compositions and methods for treating surfaces
FR2783708B1 (fr) Kit de maquillage associant des compositions filmogenes
DE69506842D1 (de) Verfahren zur Herstellung von granularen Waschmittelkomponenten oder Waschmittelzusammensetzungen
ATE190093T1 (de) Kaltreiniger auf basis von alkanen oder cycloalkanen und einer organischen verbindung mit einer ketofunktion
TR199900424A2 (tr) Yüzey temizleme aleti.
AR017402A1 (es) Una composicion blanqueadora para eliminar manchas de sustratos, un metodo para blanquear un sustrato manchado y un metodo para inhibir el desarrollomicrobiano en sustratos de superficie flexible o dura
FR2763842B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant des derives de threonine ou de serine
WO2004096121A3 (en) Compositions and methods for preventing infection